EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Biological Evaluation of N‐(1H‐Indol‐6‐ylmethyl)benzenesulfonamide Analogs as Metabolic Inhibitors of Mitochondrial ATP Production in Pancreatic Cancer Cells

Zachary C Brandeburg, Sakariyau A Waheed, Carina A Derewonko, Caroline E Dunn, Ethan C Pfeiffer, Ann Marie E Flusche, Robert J Sheaff, Angus A Lamar iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Zachary C Brandeburg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The University of Tulsa, 800 South Tucker Drive, Tulsa, OK, 74104, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Sulfonamides, Adenosine Triphosphate, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Oklahoma Center for the Advancement of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A library of 26 indolyl sulfonamides and 12 amide and ester analogs based upon the 6‐indolyl framework has been synthesized in an effort to target pancreatic cancer. The cytotoxicity of the indolyl sulfonamide compounds has been determined using a traditional (48‐h compound exposure) assay against 7 pancreatic cancer cell lines and 1 non‐cancerous cell line. The potential role of the compounds as metabolic inhibitors of ATP production was evaluated using a rapid screening (2‐h compound exposure) assay developed within our laboratories. The IC 50 values of the active compounds were determined using the rapid assay and six compounds displayed an IC 50 value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsSulfonamidesAdenosine TriphosphateAntineoplastic AgentsDrug Screening Assays, AntitumorMitochondriaHumansStructure-Activity RelationshipCell Line, TumorMolecular StructureIndolesCell ProliferationDose-Response Relationship, DrugBenzenesulfonamides

Stichwörter der Autor:innen

Chemotherapy resistanceIndolePancreatic cancerSulfonamideTargeted cancer therapy

Substanzen

SulfonamidesAdenosine TriphosphateAntineoplastic AgentsIndolesBenzenesulfonamides

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, The University of Tulsa, 800 South Tucker Drive, Tulsa, OK, 74104, USA.

ORCID-Profile: Angus A Lamar

Förderung

  • Oklahoma Center for the Advancement of Science and Technology

Zitieren

APA

Brandeburg, Z. C., Waheed, S. A., Derewonko, C. A., Dunn, C. E., Pfeiffer, E. C., Flusche, A. M. E., Sheaff, R. J., & Lamar, A. A. (2025). Synthesis and Biological Evaluation of N‐(1H‐Indol‐6‐ylmethyl)benzenesulfonamide Analogs as Metabolic Inhibitors of Mitochondrial ATP Production in Pancreatic Cancer Cells. ChemMedChem. https://doi.org/10.1002/cmdc.202400536

Vancouver

Brandeburg ZC, Waheed SA, Derewonko CA, Dunn CE, Pfeiffer EC, Flusche AME, et al. Synthesis and Biological Evaluation of N‐(1H‐Indol‐6‐ylmethyl)benzenesulfonamide Analogs as Metabolic Inhibitors of Mitochondrial ATP Production in Pancreatic Cancer Cells. ChemMedChem. 2025. doi:10.1002/cmdc.202400536

BibTeX
@article{Brandeburg2025,
  author = {Brandeburg, Zachary C and Waheed, Sakariyau A and Derewonko, Carina A and Dunn, Caroline E and Pfeiffer, Ethan C and Flusche, Ann Marie E and Sheaff, Robert J and Lamar, Angus A},
  title = {Synthesis and Biological Evaluation of N‐(1H‐Indol‐6‐ylmethyl)benzenesulfonamide Analogs as Metabolic Inhibitors of Mitochondrial ATP Production in Pancreatic Cancer Cells},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400536}
}
Kostenlos starten →